Terumo Corporation
Overview
Terumo Corporation is a global medical technology company that manufactures and sells medical products and equipment, and also makes strategic investments in early-stage companies through its corporate venture capital arm, Terumo Ventures.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Endovascular Engineering, Inc. | Feb 2025 | Series B | Co-investor |
| Wision A.I. | Sep 2019 | Accelerator | Co-investor |
| Diabeloop | Jun 2022 | Series C | Co-investor |
For institutional investors. Book with your work email.
Key People
Jim Kakaflikas
Managing Director Australia and New Zealand
Olivia Johnson
Strategic Partner
Hiroshi Shiono
Sr. Principal Researcher
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Terumo Corporation based?
Terumo Corporation is headquartered in Japan.
When was Terumo Corporation founded?
Terumo Corporation was founded in 1921.
How many portfolio companies does Terumo Corporation have?
Terumo Corporation has 4 portfolio companies in Caplight's dataset.
What are some companies in Terumo Corporation's portfolio?
Portfolio companies visible on Caplight include Endovascular Engineering, Inc., Wision A.I., Diabeloop.
What was Terumo Corporation's most recent investment shown here?
Terumo Corporation's most recent investment in this portfolio sample was in Endovascular Engineering, Inc. in 2025.
What sectors does Terumo Corporation focus on?
Terumo Corporation focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Enterprise Software.
What company stages does Terumo Corporation focus on?
Terumo Corporation typically invests at the Mid stage.
What is Terumo Corporation's AUM?
Terumo Corporation's assets under management are estimated between $75.0M and $75.0M.